Research projects
Cima Universidad de Navarra
-
Next Generation Gene Delivery TechnologiesActive
Advancing genetic medicines for inherited kidney disease
Cima Principal Investigator: Nerea ZabaletaFunder: Comisión EuropeaAward year 2025 -
Radioimmunotherapy strategies for pediatric tumorsActive
RYC2024-050746-I - Sara Labiano
Cima Principal Investigator: Sara Labiano AlmiñanaFunder: Ministerio de Ciencia, Innovación y UniversidadesAward year 2025 -
Machine Learning in BiomedicineActive
Accelerating CAR-T cell therapies through high-throughput screening based on deep learning
Cima Principal Investigators: Mikel Hernáez, Juan Roberto Rodríguez MadozFunder: Asociación Española contra el CáncerAward year 2025 -
Myeloid PathologyActive
Identification of master transcriptional regulators as new therapeutic targets for myelodysplastic syndromes
Cima Principal Investigator: Teresa Ezponda ItoizFunder: Asociación Española contra el CáncerAward year 2025 -
Advanced Therapies for Rare Liver DiseasesActive
Development of a new universal, long-term gene therapy for Wilson's disease
Cima Principal Investigator: Gloria González-AseguinolazaFunder: Ministerio de Ciencia, Innovación y UniversidadesAward year 2025 -
Enable TechnologiesActive
MyHEART: Development of advanced manufacturing processes for the creation of a mature ventricular assist device (BioVAD) on a therapeutic scale
Cima Principal Investigator: Manuel Mazo VegaFunder: Gobierno de NavarraAward year 2025 -
Next Generation Gene Delivery TechnologiesActive
Advances in genetic medicine for hereditary kidney diseases
Cima Principal Investigator: Nerea ZabaletaFunder: Ministerio de Ciencia, Innovación y UniversidadesAward year 2025 -
Gene Therapy for Monogenic EncephalopathiesActive
Optimization of messenger RNA trans-splicing for the treatment of genetic encephalopathies
Cima Principal Investigator: Rubén Hernández AlcocebaFunder: Ministerio de Ciencia, Innovación y UniversidadesAward year 2025 -
Advanced Therapies for Rare Liver DiseasesActive
Optimization of genetic treatments for Wilson's disease based on the identification of factors that limit their therapeutic efficacy
Cima Principal Investigator: Gloria González-AseguinolazaFunder: Ministerio de Ciencia, Innovación y UniversidadesAward year 2025 -
Immunomodulation and Tumor MicroenvironmentActive
CAR-T therapy, tumor microenvironment, genetic modification, immunotherapy, solid tumor, metabolic reprogramming, tumor resistance
Cima Principal Investigator: Teresa Lozano MoredaFunder: Ministerio de Ciencia, Innovación y UniversidadesAward year 2025